Literature DB >> 23992930

Coordinated proteomic signature changes in immune response and complement proteins in acute myocardial infarction: the implication of serum amyloid P-component.

Judit Cubedo1, Teresa Padró, Lina Badimon.   

Abstract

BACKGROUND: Patient outcomes after acute myocardial infarction (AMI) are influenced by the combined activation of several distinct interrelated signaling pathways. Specifically acute-phase response proteins can neutralize inflammatory agents, minimize the extent of tissue damage, and participate in tissue repair and regeneration. We have investigated the evolution of immune response and complement system-related proteins in the early and late phase post-AMI and their potential association with tissue damage after the ischemic event.
METHODS: Serum was analyzed by 2D-electrophoresis and mass-spectrometry (MALDI-TOF/TOF) in controls and de novo AMI-patients within the first 6h after onset (admission time), and 3 days after.
RESULTS: Among differential proteins two functional groups showed coordinated changes: immune response-inflammation (alpha-1B-glycoprotein, fetuin-A, serum amyloid P-component (SAP), and complex-forming glycoprotein HC) and complement system (C1r, C3 and factor-B). Immune-related proteins showed a decrease 3 days after admission except for SAP that depicted a progressive increase from the early phase. Specifically, fetuin-A decrease was associated with the extent of myocardial necrosis. C1r and C3 were increased in the early phase with a subsequent decrease 3 days after, being C1r levels at admission correlated with necrosis and troponin-T and GPT levels. Contrarily, factor-B was decreased in the early and late phase post-AMI.
CONCLUSIONS: Our results demonstrate that in the late phase post-AMI there is a coordinated decrease in immune response-inflammation proteins, except for SAP which showed an increase related to the specific activation of the classical complement pathway. Changes in immunity and complement-related proteins affect the severity of organ damage influencing prognosis after AMI.
© 2013.

Entities:  

Keywords:  Acute myocardial infarction; Acute-phase response; Complement; Immunity; Inflammation; Proteomics

Mesh:

Substances:

Year:  2013        PMID: 23992930     DOI: 10.1016/j.ijcard.2013.07.181

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Inflammatory protein response in CDKL5-Rett syndrome: evidence of a subclinical smouldering inflammation.

Authors:  Alessio Cortelazzo; Claudio de Felice; Silvia Leoncini; Cinzia Signorini; Roberto Guerranti; Roberto Leoncini; Alessandro Armini; Luca Bini; Lucia Ciccoli; Joussef Hayek
Journal:  Inflamm Res       Date:  2016-11-29       Impact factor: 4.575

2.  iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease.

Authors:  Tatiana Martin-Rojas; Laura Mourino-Alvarez; Sergio Alonso-Orgaz; Esther Rosello-Lleti; Enrique Calvo; Luis Fernando Lopez-Almodovar; Miguel Rivera; Luis R Padial; Juan Antonio Lopez; Fernando de la Cuesta; Maria G Barderas
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

3.  Fetuin-A is related to infarct size, left ventricular function and remodelling after acute STEMI.

Authors:  Hans-Josef Feistritzer; Gert Klug; Sebastian J Reinstadler; Marie-Therese Gröber; Johannes Mair; Rudolf Kirchmair; Benjamin Henninger; Wolfgang-Michael Franz; Bernhard Metzler
Journal:  Open Heart       Date:  2015-06-26

4.  Effects of a Carob-Pod-Derived Sweetener on Glucose Metabolism.

Authors:  Carmen Lambert; Judit Cubedo; Teresa Padró; Gemma Vilahur; Sergi López-Bernal; Milagros Rocha; Antonio Hernández-Mijares; Lina Badimon
Journal:  Nutrients       Date:  2018-02-27       Impact factor: 5.717

5.  Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study.

Authors:  Carmen Lambert; Judit Cubedo; Teresa Padró; Joan Sánchez-Hernández; Rosa M Antonijoan; Antonio Perez; Lina Badimon
Journal:  Nutrients       Date:  2017-06-13       Impact factor: 5.717

6.  Bioactive Sphingolipids, Complement Cascade, and Free Hemoglobin Levels in Stable Coronary Artery Disease and Acute Myocardial Infarction.

Authors:  T Jadczyk; K Baranski; M Syzdol; E Nabialek; W Wanha; R Kurzelowski; M Z Ratajczak; M Kucia; B Dolegowska; M Niewczas; J Zejda; W Wojakowski
Journal:  Mediators Inflamm       Date:  2018-07-09       Impact factor: 4.711

7.  Proteomic Analysis Identifies FNDC1, A1BG, and Antigen Processing Proteins Associated with Tumor Heterogeneity and Malignancy in a Canine Model of Breast Cancer.

Authors:  Yonara G Cordeiro; Leandra M Mulder; René J M van Zeijl; Lindsay B Paskoski; Peter van Veelen; Arnoud de Ru; Ricardo F Strefezzi; Bram Heijs; Heidge Fukumasu
Journal:  Cancers (Basel)       Date:  2021-11-24       Impact factor: 6.639

8.  Platelet-released extracellular vesicles: the effects of thrombin activation.

Authors:  Rosa Suades; Teresa Padró; Gemma Vilahur; Lina Badimon
Journal:  Cell Mol Life Sci       Date:  2022-03-14       Impact factor: 9.207

9.  Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology.

Authors:  Elisa Diaz-Riera; Maísa García-Arguinzonis; Laura López; Xavier Garcia-Moll; Lina Badimon; Teresa Padro
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

10.  Vitamin D Correction Down-Regulates Serum Amyloid P Component Levels in Vitamin D Deficient Arab Adults: A Single-Arm Trial.

Authors:  Osama E Amer; Malak N K Khattak; Abdullah M Alnaami; Naji J Aljohani; Nasser M Al-Daghri
Journal:  Nutrients       Date:  2020-09-21       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.